2003
DOI: 10.1007/bf03040336
|View full text |Cite
|
Sign up to set email alerts
|

Predictive role of serum procollagen III peptide and Knodell’s index in survival prognosis of patients with hepatitis B virus liver cirrhosis

Abstract: Combining PIIIP and KI with other prognostic parameters is useful in achieving a better precision of survival prognosis in patients with HBV liver cirrhosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
1
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 27 publications
0
1
0
Order By: Relevance
“…[1113] El-Mezayen et al [11] combined serum IVC and LN levels with liver biochemical indexes to develop a fibrosis discriminant scoring system and found that the scoring system estimated significant liver fibrosis with 79% sensitivity and 88% specificity in patients with chronic hepatitis C. Incorporation of serum levels of PIIINP into conventional assessment approaches, such as the Knodell index, has been found to improve the accuracy of prediction of the survival prognosis in patients with hepatitis B virus liver cirrhosis. [12] In addition, serum HA has also been tested as a biomarker to evaluate the severity of liver fibrosis. [13] …”
Section: Introductionmentioning
confidence: 99%
“…[1113] El-Mezayen et al [11] combined serum IVC and LN levels with liver biochemical indexes to develop a fibrosis discriminant scoring system and found that the scoring system estimated significant liver fibrosis with 79% sensitivity and 88% specificity in patients with chronic hepatitis C. Incorporation of serum levels of PIIINP into conventional assessment approaches, such as the Knodell index, has been found to improve the accuracy of prediction of the survival prognosis in patients with hepatitis B virus liver cirrhosis. [12] In addition, serum HA has also been tested as a biomarker to evaluate the severity of liver fibrosis. [13] …”
Section: Introductionmentioning
confidence: 99%
“…This study draws parallels from liver fibrosis researches, where ECM serum levels, alongside liver biochemistry markers, have facilitated pulmonary fibrosis assessment and prognosis ( El-Mezayen et al, 2015 ; Babic et al, 2003 ; Neuman et al, 2016 ). By analyzing serum levels of LN, IV COL, PIIINP, and HA in PC19-PF patients against pulmonary function tests and high-resolution computed tomography (HRCT) scores, this research seeks to elucidate their relationship with disease severity and survival prognosis in PC19-PF.…”
Section: Introductionmentioning
confidence: 99%
“…In the past, the serum levels of four ECM molecules have been tested as biological markers for assessing liver fibrosis and predicting the prognosis of patients with liver diseases ( El-Mezayen et al, 2015 ; Babic et al, 2003 ; Neuman et al, 2016 ). Additionally, patients with pulmonary function deterioration and radiographic progression exhibited higher PIIINP and HA levels than those with stable disease ( Bjermer et al, 1989 ).…”
Section: Introductionmentioning
confidence: 99%